207 related articles for article (PubMed ID: 30550488)
1. Effect of Macrolide Prophylactic Therapy on AIDS-Defining Conditions and HIV-Associated Mortality.
Pasayan MKU; S Mationg ML; Boettiger D; Lam W; Zhang F; Ku SW; Merati TP; Chaiwarith R; Cuong DD; Yunihastuti E; Kiertiburanakul S; Van Kinh N; Avihingsanon A; Sun LP; Kamarulzaman A; Kantipong P; Kumarasamy N; Pujari S; Heng Sim BL; Ng OT; Choi JY; Tanuma J; Ross J; A Ditangco R
J Acquir Immune Defic Syndr; 2019 Apr; 80(4):436-443. PubMed ID: 30550488
[TBL] [Abstract][Full Text] [Related]
2. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.
Currier JS; Williams PL; Koletar SL; Cohn SE; Murphy RL; Heald AE; Hafner R; Bassily EL; Lederman HM; Knirsch C; Benson CA; Valdez H; Aberg JA; McCutchan JA
Ann Intern Med; 2000 Oct; 133(7):493-503. PubMed ID: 11015162
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. Terry Beirn Community Programs for Clinical Research on AIDS.
El-Sadr WM; Burman WJ; Grant LB; Matts JP; Hafner R; Crane L; Zeh D; Gallagher B; Mannheimer SB; Martinez A; Gordin F
N Engl J Med; 2000 Apr; 342(15):1085-92. PubMed ID: 10766581
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infections in HIV-AIdS.
Paul SM
N J Med; 2004 Nov; 101(11):25-31; quiz 32-4. PubMed ID: 15605797
[No Abstract] [Full Text] [Related]
7. Presence of macrolide resistance in respiratory flora of HIV-Infected patients receiving either clarithromycin or azithromycin for Mycobacterium avium complex prophylaxis.
Aberg JA; Wong MK; Flamm R; Notario GF; Jacobson MA
HIV Clin Trials; 2001; 2(6):453-9. PubMed ID: 11742432
[TBL] [Abstract][Full Text] [Related]
8. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
Lange CG; Woolley IJ; Brodt RH
Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individuals.
Faris MA; Raasch RH; Hopfer RL; Butts JD
Ann Pharmacother; 1998 May; 32(5):564-73. PubMed ID: 9606478
[TBL] [Abstract][Full Text] [Related]
10. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy.
Rossi M; Flepp M; Telenti A; Schiffer V; Egloff N; Bucher H; Vernazza P; Bernasconi E; Weber R; Rickenbach M; Furrer H;
Swiss Med Wkly; 2001 Aug; 131(31-32):471-7. PubMed ID: 11641970
[TBL] [Abstract][Full Text] [Related]
11. Current strategies for the prevention and treatment of disseminated Mycobacterium avium complex infection in patients with AIDS.
Wright J
Pharmacotherapy; 1998; 18(4):738-47. PubMed ID: 9692648
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for AIDS-defining opportunistic illnesses, 1992-1997.
Jones JL; Hanson DL; Dworkin MS; Alderton DL; Fleming PL; Kaplan JE; Ward J
MMWR CDC Surveill Summ; 1999 Apr; 48(2):1-22. PubMed ID: 12412613
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
Karakousis PC; Moore RD; Chaisson RE
Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
[TBL] [Abstract][Full Text] [Related]
14. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4 <50 cells/μL who are virologically suppressed on cART?
Yangco BG; Buchacz K; Baker R; Palella FJ; Armon C; Brooks JT;
AIDS Patient Care STDS; 2014 Jun; 28(6):280-3. PubMed ID: 24833016
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV; Dubé MP; Sattler FR; Forthal DN; Kemper CA; Dunne MW; Parenti DM; Lavelle JP; White AC; Witt MD; Bozzette SA; McCutchan JA
N Engl J Med; 1996 Aug; 335(6):392-8. PubMed ID: 8676932
[TBL] [Abstract][Full Text] [Related]
16. Discontinuation of Mycobacterium avium complex prophylaxis in patients with a rise in CD4 cell count following highly active antiretroviral therapy.
Gill J; Moyle G; Nelson M
AIDS; 1998 Apr; 12(6):680. PubMed ID: 9583614
[No Abstract] [Full Text] [Related]
17. Prevention of disseminated Mycobacterium avium complex infection with reduced dose clarithromycin in patients with advanced HIV disease.
Hewitt RG; Papandonatos GD; Shelton MJ; Hsiao CB; Harmon BJ; Kaczmarek SR; Amsterdam D
AIDS; 1999 Jul; 13(11):1367-72. PubMed ID: 10449290
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.
Gordin F; Masur H
Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of disseminated Mycobacterium avium complex infection in human immunodeficiency virus-infected individuals.
Shafran SD
Int J Infect Dis; 1998; 3(1):39-47. PubMed ID: 9831675
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of an AIDS patient with prolonged Mycobacterium avium bacteremia, high HIV RNA, HBV infection, Kaposi's sarcoma and cytomegalovirus retinitis.
Furukawa Y; Hamada H; Kamikawaji K; Unoki T; Inoue H; Tashiro Y; Okamoto M; Baba M; Hashiguchi T
J Infect Chemother; 2020 Feb; 26(2):279-281. PubMed ID: 31543435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
